Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2025/04/084023
CTRI/2025/04/084023
Not yet recruiting
Phase 3 4

Anatomical consideration of Hridaya(Anahata) chakra and its applied anatomy with special reference to Stage 1 Hypertension and cardiac electrical parameters

Institute of Medical Science, Banaras Hindu University1 site in 1 country140 target enrollmentStarted: April 12, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Institute of Medical Science, Banaras Hindu University
Enrollment
140
Locations
1
Primary Endpoint
Systolic and diastolic blood pressure
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

140 cases of Stage 1 Hypertension will be included in the interventional study which will be randomly divided into 4 groups of 35 patients in each group. First group will be the control group prescribed with Telmisartan 20mg. Second group will be prescribed with Telmisartan 20mg along with Sheetali pranayama and Yoganidra. Third group will be prescribed with Sarpagandha ghanvati 250 mg twice daily. Fourth group will be prescribed with Sarpagandha ghanvati 250 mg twice daily along with Sheetali pranayama and Yoganidra. It is expected that Sheetali pranayama and Yoganidra will reduce blood pressure in patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
40.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Willing to give consent to participate in the study.
  • •Patients in age group between 40-60 years of either sex irrespective of religion, socio- economic status and occupation.
  • •Patients having Grade1 Hypertension (SBP= 140-159mmHg & DBP= 90-99mmHg).

Exclusion Criteria

  • •Patients age less than 40 or greater than 60 years.
  • •Patients with less than 140/90 mmHg and greater than 159/99 mmHg blood pressure.
  • •Patients with Diabetes Mellitus, thyroid disorders.
  • •Patients on steroid medicines or having Peptic ulcer.
  • •Subjects who are pregnant and lactating.
  • •Patients with habits of smoking and alcoholism.
  • •Subjects who are with chronic illness except metabolic syndromes.
  • •or hearing impairment.
  • •Subjects who are taking any kind of sedatives or psychological treatments.
  • •Subjects who are having other renal, hepatic, cardiovascular or respiratory disorders (such as asthma, bronchitis, or excessive mucus).

Outcomes

Primary Outcomes

Systolic and diastolic blood pressure

Time Frame: 3 months with follow up at 1 month interval

Secondary Outcomes

  • BMI(RFT)

Investigators

Sponsor
Institute of Medical Science, Banaras Hindu University
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Gayathri R

Banaras Hindu University

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Not Applicable
Managing the primary hypertension in adults with individualized dynamized homoeopathic medicine - A prospective study
CTRI/2025/09/094729Sainath Homoeopathic Hospital50
Not yet recruiting
Not Applicable
Effect of equi-ratio breathing on heart and lung health in primary hypertension.
CTRI/2025/03/081736Dr Abhishek poojari78
Not yet recruiting
Phase 3
Anti hypertensive activity of polyherbal formulation
CTRI/2025/01/079691BVG life sciences Limited60
Not yet recruiting
Phase 2/3
A study to see how effective two herbal oil treatments are (Kumari Siddha Taila and Shatpushpa Siddha Taila) when used as enemas for helping women with PCOS who arent ovulating.
CTRI/2025/07/090732Tilak ayurvedic mahavidyalaya rasta peth Pune50
Not yet recruiting
Phase 2/3
A Comparative Study Of Efficacy Of Chaturbeej Churna With Latakaranj Churna In The Management Of Garbhashay Shodhan
CTRI/2024/10/076031Tilak Ayurved Mahavidyalay50